ACHC Q2 adj. EPS $0.38 vs. est. $0.35, beat by $0.03; revenue $865.8Mm vs. est. $844.2Mm, above expectations on inpatient growth but pressur

ACHC Q2 adj. EPS $0.38 vs. est. $0.35, beat by $0.03; revenue $865.8Mm vs. est. $844.2Mm, above expectations on inpatient growth but pressured by higher costs; Q2 adj. EBITDA $149.2Mm vs. est. $148.2Mm; FY26 guidance updated to revenue $3.40–$3.45B vs est $3.409B, adj. EBITDA $590–$615Mm vs. est. $596Mm, adj. EPS $1.45–$1.60 vs est $1.51, and CAPEX $235–$255Mm; shares -5%